Bayer | BAYN - Selling And Administration Expenses

Stock Price
37.71
Daily Change
-0.47 -1.23%
Monthly
-7.32%
Yearly
64.89%
Q2 Forecast
36.04

Bayer reported EUR3.7B in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
Air Liquide EUR 2.57B 1.27B Dec/2024
Akzo Nobel EUR 804M 7M Mar/2026
Alcon AG USD 882M 19M Mar/2026
Amarin USD 18.97M 1.03M Dec/2025
Arkema EUR 228.6M 15.6M Mar/2026
AstraZeneca USD 5.06B 455M Mar/2026
BASF EUR 2.13B 84M Mar/2026
Bayer EUR 3.7B 356M Mar/2026
Beiersdorf EUR 271M 51M Dec/2025
Corteva USD 877M 17M Mar/2026
Covestro EUR 445M 8M Dec/2025
Essilor EUR 5.62B 4.53B Dec/2025
Fresenius EUR 819M 143M Dec/2025
Fresenius Medical Care EUR 749M 36M Mar/2026
Genmab DKK 208M 60M Dec/2025
Givaudan CHF 561M 25M Dec/2025
GlaxoSmithKline GBP 2.12B 558M Mar/2026
GRIFOLS EUR 281M 5.7M Mar/2026
Henkel EUR 3.49B 38M Dec/2025
Hikma Pharmaceutical USD 288M 149M Dec/2025
Johnson Matthey GBP 170M 87M Dec/2025
Linde USD 880M 40M Dec/2025
Merck EUR 1.6B 136M Dec/2025
Novartis USD 3.14B 296M Mar/2026
Nutrien USD 963M 18M Mar/2026
Philips EUR 1.18B 121M Mar/2026
PPG Industries USD 905M 71M Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Sanofi EUR 2.33B 419M Mar/2026
SAP EUR 2.5B 129M Mar/2026
Solvay EUR 131M 24M Mar/2026
UCB EUR 1.47B 193M Dec/2025
Vinci EUR 197M 49M Jun/2025